Find a TenderAwarded without competition
Published 1 Aug 2025, 15:48 BST

Official UK procurement notice

Perinatal Immunisation Services in Dorset to NHS England

Official notice

Authority: NHS England (Central government)

ServicesAward procedure without prior publication of a call for competition
Awarded value£1,250,000published contract · exc. VAT
Awarded 25 Jul 2025no call for competition
Awarded to Dorset Healthcare University Foundation Trust

What is being bought

Published requirement description

NHS England South West is commissioning Perinatal Immunisation Services within Dorset.

Perinatal Immunisation Services being commissioned include Pertussis, Flu and COVID-19 vaccinations for pregnant women, Bacillus Calmette-Guérin (BCG) vaccinations for newborn infants, and the roll out of the Respiratory Syncytial Virus (RSV) vaccination programme for pregnant woman over 28 Weeks.

The Commissioner intends to contract for the Services using the latest version of the NHS Standard Contract. The contract term will be for a duration of 3 years with a 2 year optional extension, and will commence on 1st September 2025. The total estimated contract value is £1,250,000 across the 5 years.

This notice is placed to set out NHS England South West's (the Commissioner's) intention to award a contract under the Most Suitable Provider Process of the Provider Selection Regime (PSR).

CPV: General anti-infectives for systemic use and vaccines · Miscellaneous health services

The lotProcurement structure

single lot · no lot value published
Lot #1Awarded
Delivery: South West
Extensions: 2 years optional extension.

Procedure terms & legal framework

From the official record · publisher note attached
Procedure method
Award procedure without prior publication of a call for competition
Legal basis
CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category
Services
Notice status
Awarded without competition
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Stand-alone contract (no framework)
Competition type
Direct award (no call for competition)
GPA / WTO covered
Unspecified in notice
Recurring procurement
Unspecified in notice
First published
1 Aug 2025, 15:48 BST
Last source update
14 Aug 2025, 12:55 BST
Authority reference
C369879
FTS notice number
2025/S 000-048737
Classification (CPV)
General anti-infectives for systemic use and vaccinesMiscellaneous health services
Delivery area
South West (UKK25)
Official registry OCID
ocds-h6vhtk-056b94 Find a Tender
Why no open competition
The procurement falls outside the scope of application of the directive
Published justification

This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to decision makers by 13/08/2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR'.

Publisher note: The decision to award this contract in line with the Most Suitable Provider Process was based on evaluation against the basic selection criteria, and the 5 key criteria (see below), which were assessed on a "Pass" / "Fail" basis, the key criteria were weighted equally. Assessment of the providers were based on publicly available information, evidence available through their existing contract with NHS England South West where one existed, as well as further information that was requested as part of the MSP process. Dorset Healthcare University Foundation Trust attained a "pass" on all elements of the basic selection criteria and the key criteria assessment, meeting the requirements of the assessment. Award decisions have been made by the Head of Public Health Commissioning, with key decision makers being Senior Commissioning Manager. No conflicts of interest were declared. The key criteria for review were as follows: a. Quality and innovation i. Provider to give an example of an improvement in care delivery relevant to the sexual assault and abuse services pathway that they have implemented within the last three years ii. Review of evidence of relevant accreditations or service development initiatives e.g. Bluestar pre-trial guidance iii. Evidence of robust clinical governance and safeguarding policies and frameworks relevant to the delivery of sexual assault and abuse services iv. Evidence of quality assurance processes for monitoring and reporting purposes. b. Value i. Assurance that the provider will be able to meet all of the requirements of the service over the life of the contract within the stated annual and overall financial envelope ii. Assurance of the provider's financial planning and resilience, including the management of financial risk. c. Integration, collaboration and service sustainability i. Evidence of collaborative working and integrated delivery within the sexual violence pathway in, around and relevant to Devon and Cornwall ii. Review of provider workforce strategies including recruitment & retention and training iii. Evidence of successful recruitment and retention of senior and specialist workforce. d. Improving access, reducing health inequalities and facilitating choice i. Evidence of the provider's understanding of the stakeholders they will need to work with to deliver a high quality service ii. Evidence of the provider's ability to support adults with complex trauma who have experienced sexual violence iii. Health inequalities reporting and evidence of improvement e. Social value i. Evidence that the provider over the last five years has taken measures to reduce their carbon emissions and/or contributed to the local community with recruitment opportunities and career development ii. Examples of co-production and elevating the survivor voice iii. Evidence of relevant evaluation, research and best practice development. This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to the relevant authority by midnight on 13/08/2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR. Written representations should be sent to: scwcsu.procurement@nhs.net

Notice history

2 releases on Find a Tender
Published amendments (1)

The Commissioner intends to contract for the Services using the latest version of the NHS Standard Contract. The contract was formally awarded on 14th August 2025 and will commence on 1st September 2025. The contract term will be for a duration of 3 years, ending on 31st August 2028, with a 2 year optional extension. The total estimated contract value is £1,250,000 across the 5 years. No conflicts…

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast
Awards 1
Awarded value £1,250,0001 contract exc. VAT
Bids received 2
Contracts signed 1latest 25 Jul 2025
Awarded toValueDateStatus
Dorset Healthcare University Foundation Trust£1,250,000 †—Awarded

Contracts

Bid statistics published by the authority

BidsSMEVCSEValid bid range
2bids———

Contracting authority & participating public bodies

NHS England

Contracting authorityCentral GovernmentBody governed by public lawHealth Wellington House, 133-135 Waterloo Road, London, London, SE1 8UGContact email

Bidders & participating suppliers

1 commercial party on the notice

Official documents & specifications

Official links; attachments are not copied

No document links were published on the notice.